نتایج جستجو برای: nanobodies

تعداد نتایج: 541  

2012
Guy Caljon Benoît Stijlemans Dirk Saerens Jan Van Den Abbeele Serge Muyldermans Stefan Magez Patrick De Baetselier

BACKGROUND The discovery of Nanobodies (Nbs) with a direct toxic activity against African trypanosomes is a recent advancement towards a new strategy against these extracellular parasites. The anti-trypanosomal activity relies on perturbing the highly active recycling of the Variant-specific Surface Glycoprotein (VSG) that occurs in the parasite's flagellar pocket. METHODOLOGY/PRINCIPAL FINDI...

Journal: :Cancer research 2004
Virna Cortez-Retamozo Natalija Backmann Peter D Senter Ullrich Wernery Patrick De Baetselier Serge Muyldermans Hilde Revets

Nanobodies are the smallest fragments of naturally occurring single-domain antibodies that have evolved to be fully functional in the absence of a light chain. Nanobodies are strictly monomeric, very stable, and highly soluble entities. We identified a nanobody with subnanomolar affinity for the human tumor-associated carcinoembryonic antigen. This nanobody was conjugated to Enterobacter cloaca...

2013
Christian Löw Yin Hoe Yau Els Pardon Caroline Jegerschöld Lisa Wåhlin Esben M. Quistgaard Per Moberg Susana Geifman-Shochat Jan Steyaert Pär Nordlund

Mechanosensitive channels (MS) are integral membrane proteins and allow bacteria to survive sudden changes in external osmolarity due to transient opening of their pores. The efflux of cytoplasmic osmolytes reduces the membrane tension and prevents membrane rupture. Therefore these channels serve as emergency valves when experiencing significant environmental stress. The preparation of high qua...

2017
Simon Boje Hansen Nick Stub Laursen Gregers Rom Andersen Kasper R. Andersen

The generation of high-quality protein crystals and the loss of phase information during an X-ray crystallography diffraction experiment represent the major bottlenecks in the determination of novel protein structures. A generic method for introducing Hg atoms into any crystal independent of the presence of free cysteines in the target protein could considerably facilitate the process of obtain...

Journal: :Journal of molecular biology 2013
Tim Guilliams Farah El-Turk Alexander K Buell Elizabeth M O'Day Francesco A Aprile Elin K Esbjörner Michele Vendruscolo Nunilo Cremades Els Pardon Lode Wyns Mark E Welland Jan Steyaert John Christodoulou Christopher M Dobson Erwin De Genst

Nanobodies are single-domain fragments of camelid antibodies that are emerging as versatile tools in biotechnology. We describe here the interactions of a specific nanobody, NbSyn87, with the monomeric and fibrillar forms of α-synuclein (αSyn), a 140-residue protein whose aggregation is associated with Parkinson's disease. We have characterized these interactions using a range of biophysical te...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2011
Katarzyna Domanska Saskia Vanderhaegen Vasundara Srinivasan Els Pardon Florine Dupeux Jose A Marquez Sofia Giorgetti Monica Stoppini Lode Wyns Vittorio Bellotti Jan Steyaert

Atomic-level structural investigation of the key conformational intermediates of amyloidogenesis remains a challenge. Here we demonstrate the utility of nanobodies to trap and characterize intermediates of β2-microglobulin (β2m) amyloidogenesis by X-ray crystallography. For this purpose, we selected five single domain antibodies that block the fibrillogenesis of a proteolytic amyloidogenic frag...

2015
Julia Maier Bjoern Traenkle Ulrich Rothbauer

Vimentin has become an important biomarker for epithelial-mesenchymal transition (EMT), a highly dynamic cellular process involved in the initiation of metastasis and cancer progression. To date there is no approach available to study endogenous vimentin in a physiological context. Here, we describe the selection and targeted modification of novel single-domain antibodies, so-called nanobodies,...

2013
Jan Terje Andersen Maria Gonzalez-Pajuelo Stian Foss Ole J. B. Landsverk Débora Pinto Alexander Szyroki Hans J. de Haard Michael Saunders Peter Vanlandschoot Inger Sandlie

FcRn is a key player in several immunological and non-immunological processes, as it mediates maternal-fetal transfer of IgG, regulates the serum persistence of IgG and albumin, and transports both ligands between different cellular compartments. In addition, FcRn enhances antigen presentation. Thus, there is an intense interest in studies of how FcRn binds and transports its cargo within and a...

2015
Peter Bannas Alexander Lenz Valentin Kunick William Fumey Björn Rissiek Joanna Schmid Friedrich Haag Axel Leingärtner Martin Trepel Gerhard Adam Friedrich Koch-Nolte

This protocol outlines the steps required to perform ex vivo validation of in vivo near-infrared fluorescence (NIRF) xenograft imaging experiments in mice using fluorophore labelled nanobodies and conventional antibodies. First we describe how to generate subcutaneous tumors in mice, using antigen-negative cell lines as negative controls and antigen-positive cells as positive controls in the sa...

Journal: :Molecular pharmacology 2014
Dean P Staus Laura M Wingler Ryan T Strachan Soren G F Rasmussen Els Pardon Seungkirl Ahn Jan Steyaert Brian K Kobilka Robert J Lefkowitz

The biologic activity induced by ligand binding to orthosteric or allosteric sites on a G protein-coupled receptor (GPCR) is mediated by stabilization of specific receptor conformations. In the case of the β2 adrenergic receptor, these ligands are generally small-molecule agonists or antagonists. However, a monomeric single-domain antibody (nanobody) from the Camelid family was recently found t...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید